What does a Grade II–III cartilage lesion indicate in a 43-year-old patient with a focal medial compartment defect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grade II–III Cartilage Lesion Definition

A Grade II–III cartilage lesion indicates moderate cartilage damage with fragmentation and fissuring, where Grade II involves an area less than 1.5 cm in diameter and Grade III involves an area greater than 1.5 cm in diameter, according to the Outerbridge classification system 1.

Understanding the Grading System

The Outerbridge classification is the most widely used system for grading cartilage damage 1:

  • Grade 0: Normal cartilage
  • Grade 1: Cartilage softening and swelling only
  • Grade 2: Fragmentation and fissuring involving area <1.5 cm diameter
  • Grade 3: Fragmentation and fissuring involving area >1.5 cm diameter
  • Grade 4: Complete cartilage loss with exposed subchondral bone

Clinical Significance for Your 43-Year-Old Patient

For a 43-year-old patient with a focal medial compartment Grade II–III defect, this represents partial-thickness cartilage damage that has not yet progressed to bone exposure, but indicates significant structural disruption that warrants intervention 1.

Key Clinical Implications:

  • Cartilage has minimal healing capacity, so these lesions typically do not resolve spontaneously 1
  • Progressive degeneration is likely without treatment, potentially leading to full-thickness defects (Grade IV) and eventual osteoarthritis 2
  • Quality of life impact is substantial—patients with focal cartilage defects report quality of life scores comparable to those requiring knee replacement 3

Treatment Considerations for This Patient

At age 43 with a focal medial compartment defect, this patient is an ideal candidate for joint-preserving surgical intervention 1. The evidence supports:

For Lesions <4 cm²:

  • Microfracture is indicated for focal, contained lesions in patients under 50 years with minimal osteoarthritis 1
  • This involves creating 3-4 mm deep holes in subchondral bone to stimulate fibrocartilage formation 1

Critical Decision Points:

  • Lesion size matters: Grade 2 or 3 lesions <3 cm² showed favorable outcomes with microfracture 1
  • Age is favorable: Hip-preserving strategies are particularly applicable in patients ≤50 years 1
  • Compartment location: Medial compartment lesions are common and amenable to arthroscopic treatment 1

Important Caveats

Do not confuse this with diffuse osteoarthritis—focal cartilage defects represent localized damage that can be surgically addressed, unlike generalized joint degeneration 1. The distinction is critical because:

  • Focal defects may be associated with other pathology (labral tears, meniscal injuries) that requires concurrent treatment 1
  • Early detection and management may prevent progression to full joint degeneration 1
  • Nonsurgical management is temporizing only—it does not address the underlying structural problem 1

The presence of Grade II–III changes indicates the window for joint preservation is still open, but intervention should not be delayed as progression to Grade IV significantly limits treatment options and worsens prognosis 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.